private:stratifyermolecularpathologygmbh-2
|
1487048
|
Jun 3rd, 2019 12:00AM
|
STRATIFYER Molecular Pathology GmbH
|
50
|
2.00
|
Open
|
Biotechnology
|
Jun 3rd, 2019 03:18PM
|
Jun 3rd, 2019 03:18PM
|
The highly experienced research team founding the STRATIFYER Molecular Pathology GmbH has developed techniques to analyze routine tumor material for sophisticated molecular analysis. A specialized process has been developed that guarantees fast and reliable assessment of prognostic and predictive gene signatures in mid-throughput fashion. This technology has been exploited for multiple years to enable in-depth genomic research accompanying large clinical trials. First pathology labs have been powered by STRATIFYER Molecular Pathology GmbH to integrate RNA expression profiling tests in clinical routine. The molecular STRATIFYER test systems shall enable physicians to optimize anti-cancer treatment at patient’s initial diagnosis according to individual differences of the tumors.
|
Open
|
Molecular Stratification of prospective clinical trials, Nucleic Acid Extraction Techniques, Translational Research, Bioinformatics and Statistical Support
|
Open
|
Werthmannstraße 1
|
Cologne
|
|
DE
|
D-50935
|
|
STRATIFYER Molecular Pathology GmbH
|
|
Health Care Equipment & Services
|
private:stratifyermolecularpathologygmbh-2
|
1487048
|
Mar 23rd, 2018 12:00AM
|
STRATIFYER Molecular Pathology GmbH
|
48
|
2.00
|
Open
|
Biotechnology
|
Mar 23rd, 2017 10:51AM
|
Mar 23rd, 2017 10:51AM
|
The highly experienced research team founding the STRATIFYER Molecular Pathology GmbH has developed techniques to analyze routine tumor material for sophisticated molecular analysis. A specialized process has been developed that guarantees fast and reliable assessment of prognostic and predictive gene signatures in mid-throughput fashion. This technology has been exploited for multiple years to enable in-depth genomic research accompanying large clinical trials. First pathology labs have been powered by STRATIFYER Molecular Pathology GmbH to integrate RNA expression profiling tests in clinical routine. The molecular STRATIFYER test systems shall enable physicians to optimize anti-cancer treatment at patient’s initial diagnosis according to individual differences of the tumors.
|
|
|
|
|
|
|
|
|
|
STRATIFYER Molecular Pathology GmbH
|
|
Health Care Equipment & Services
|
private:stratifyermolecularpathologygmbh-2
|
1487048
|
Feb 17th, 2018 12:00AM
|
STRATIFYER Molecular Pathology GmbH
|
48
|
2.00
|
Open
|
Biotechnology
|
Feb 17th, 2018 02:25PM
|
Feb 17th, 2018 02:25PM
|
The highly experienced research team founding the STRATIFYER Molecular Pathology GmbH has developed techniques to analyze routine tumor material for sophisticated molecular analysis. A specialized process has been developed that guarantees fast and reliable assessment of prognostic and predictive gene signatures in mid-throughput fashion. This technology has been exploited for multiple years to enable in-depth genomic research accompanying large clinical trials. First pathology labs have been powered by STRATIFYER Molecular Pathology GmbH to integrate RNA expression profiling tests in clinical routine. The molecular STRATIFYER test systems shall enable physicians to optimize anti-cancer treatment at patient’s initial diagnosis according to individual differences of the tumors.
|
|
|
|
|
|
|
|
|
|
STRATIFYER Molecular Pathology GmbH
|
|
Health Care Equipment & Services
|
private:stratifyermolecularpathologygmbh-2
|
1487048
|
Feb 16th, 2018 12:00AM
|
STRATIFYER Molecular Pathology GmbH
|
48
|
2.00
|
Open
|
Biotechnology
|
Feb 16th, 2017 08:15AM
|
Feb 16th, 2017 08:15AM
|
The highly experienced research team founding the STRATIFYER Molecular Pathology GmbH has developed techniques to analyze routine tumor material for sophisticated molecular analysis. A specialized process has been developed that guarantees fast and reliable assessment of prognostic and predictive gene signatures in mid-throughput fashion. This technology has been exploited for multiple years to enable in-depth genomic research accompanying large clinical trials. First pathology labs have been powered by STRATIFYER Molecular Pathology GmbH to integrate RNA expression profiling tests in clinical routine. The molecular STRATIFYER test systems shall enable physicians to optimize anti-cancer treatment at patient’s initial diagnosis according to individual differences of the tumors.
|
|
|
|
|
|
|
|
|
|
STRATIFYER Molecular Pathology GmbH
|
|
Health Care Equipment & Services
|
private:stratifyermolecularpathologygmbh-2
|
1487048
|
Feb 15th, 2018 12:00AM
|
STRATIFYER Molecular Pathology GmbH
|
48
|
2.00
|
Open
|
Biotechnology
|
Feb 15th, 2017 10:07AM
|
Feb 15th, 2017 10:07AM
|
The highly experienced research team founding the STRATIFYER Molecular Pathology GmbH has developed techniques to analyze routine tumor material for sophisticated molecular analysis. A specialized process has been developed that guarantees fast and reliable assessment of prognostic and predictive gene signatures in mid-throughput fashion. This technology has been exploited for multiple years to enable in-depth genomic research accompanying large clinical trials. First pathology labs have been powered by STRATIFYER Molecular Pathology GmbH to integrate RNA expression profiling tests in clinical routine. The molecular STRATIFYER test systems shall enable physicians to optimize anti-cancer treatment at patient’s initial diagnosis according to individual differences of the tumors.
|
|
|
|
|
|
|
|
|
|
STRATIFYER Molecular Pathology GmbH
|
|
Health Care Equipment & Services
|
private:stratifyermolecularpathologygmbh-2
|
1487048
|
Feb 14th, 2018 12:00AM
|
STRATIFYER Molecular Pathology GmbH
|
48
|
2.00
|
Open
|
Biotechnology
|
Feb 14th, 2017 01:50PM
|
Feb 14th, 2017 01:50PM
|
The highly experienced research team founding the STRATIFYER Molecular Pathology GmbH has developed techniques to analyze routine tumor material for sophisticated molecular analysis. A specialized process has been developed that guarantees fast and reliable assessment of prognostic and predictive gene signatures in mid-throughput fashion. This technology has been exploited for multiple years to enable in-depth genomic research accompanying large clinical trials. First pathology labs have been powered by STRATIFYER Molecular Pathology GmbH to integrate RNA expression profiling tests in clinical routine. The molecular STRATIFYER test systems shall enable physicians to optimize anti-cancer treatment at patient’s initial diagnosis according to individual differences of the tumors.
|
|
|
|
|
|
|
|
|
|
STRATIFYER Molecular Pathology GmbH
|
|
Health Care Equipment & Services
|
private:stratifyermolecularpathologygmbh-2
|
1487048
|
Feb 13th, 2018 12:00AM
|
STRATIFYER Molecular Pathology GmbH
|
48
|
2.00
|
Open
|
Biotechnology
|
Feb 13th, 2017 04:11PM
|
Feb 13th, 2017 04:11PM
|
The highly experienced research team founding the STRATIFYER Molecular Pathology GmbH has developed techniques to analyze routine tumor material for sophisticated molecular analysis. A specialized process has been developed that guarantees fast and reliable assessment of prognostic and predictive gene signatures in mid-throughput fashion. This technology has been exploited for multiple years to enable in-depth genomic research accompanying large clinical trials. First pathology labs have been powered by STRATIFYER Molecular Pathology GmbH to integrate RNA expression profiling tests in clinical routine. The molecular STRATIFYER test systems shall enable physicians to optimize anti-cancer treatment at patient’s initial diagnosis according to individual differences of the tumors.
|
|
|
|
|
|
|
|
|
|
STRATIFYER Molecular Pathology GmbH
|
|
Health Care Equipment & Services
|
private:stratifyermolecularpathologygmbh-2
|
1487048
|
Feb 12th, 2018 12:00AM
|
STRATIFYER Molecular Pathology GmbH
|
48
|
2.00
|
Open
|
Biotechnology
|
Feb 12th, 2017 04:15AM
|
Feb 12th, 2017 04:15AM
|
The highly experienced research team founding the STRATIFYER Molecular Pathology GmbH has developed techniques to analyze routine tumor material for sophisticated molecular analysis. A specialized process has been developed that guarantees fast and reliable assessment of prognostic and predictive gene signatures in mid-throughput fashion. This technology has been exploited for multiple years to enable in-depth genomic research accompanying large clinical trials. First pathology labs have been powered by STRATIFYER Molecular Pathology GmbH to integrate RNA expression profiling tests in clinical routine. The molecular STRATIFYER test systems shall enable physicians to optimize anti-cancer treatment at patient’s initial diagnosis according to individual differences of the tumors.
|
|
|
|
|
|
|
|
|
|
STRATIFYER Molecular Pathology GmbH
|
|
Health Care Equipment & Services
|
private:stratifyermolecularpathologygmbh-2
|
1487048
|
Feb 11th, 2018 12:00AM
|
STRATIFYER Molecular Pathology GmbH
|
48
|
2.00
|
Open
|
Biotechnology
|
Feb 11th, 2017 05:35AM
|
Feb 11th, 2017 05:35AM
|
The highly experienced research team founding the STRATIFYER Molecular Pathology GmbH has developed techniques to analyze routine tumor material for sophisticated molecular analysis. A specialized process has been developed that guarantees fast and reliable assessment of prognostic and predictive gene signatures in mid-throughput fashion. This technology has been exploited for multiple years to enable in-depth genomic research accompanying large clinical trials. First pathology labs have been powered by STRATIFYER Molecular Pathology GmbH to integrate RNA expression profiling tests in clinical routine. The molecular STRATIFYER test systems shall enable physicians to optimize anti-cancer treatment at patient’s initial diagnosis according to individual differences of the tumors.
|
|
|
|
|
|
|
|
|
|
STRATIFYER Molecular Pathology GmbH
|
|
Health Care Equipment & Services
|
private:stratifyermolecularpathologygmbh-2
|
1487048
|
Feb 10th, 2018 12:00AM
|
STRATIFYER Molecular Pathology GmbH
|
48
|
2.00
|
Open
|
Biotechnology
|
Feb 10th, 2017 06:43AM
|
Feb 10th, 2017 06:43AM
|
The highly experienced research team founding the STRATIFYER Molecular Pathology GmbH has developed techniques to analyze routine tumor material for sophisticated molecular analysis. A specialized process has been developed that guarantees fast and reliable assessment of prognostic and predictive gene signatures in mid-throughput fashion. This technology has been exploited for multiple years to enable in-depth genomic research accompanying large clinical trials. First pathology labs have been powered by STRATIFYER Molecular Pathology GmbH to integrate RNA expression profiling tests in clinical routine. The molecular STRATIFYER test systems shall enable physicians to optimize anti-cancer treatment at patient’s initial diagnosis according to individual differences of the tumors.
|
|
|
|
|
|
|
|
|
|
STRATIFYER Molecular Pathology GmbH
|
|
Health Care Equipment & Services
|